Aspen Pharmacare Holdings Limited
APNHF
$6.23
-$0.90-12.59%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 585.14M | 578.68M | 613.15M | 611.73M | 634.53M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 585.14M | 578.68M | 613.15M | 611.73M | 634.53M |
| Cost of Revenue | 350.08M | 346.21M | 321.26M | 320.52M | 362.46M |
| Gross Profit | 235.06M | 232.47M | 291.89M | 291.21M | 272.07M |
| SG&A Expenses | 152.52M | 150.84M | 149.94M | 149.59M | 137.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -2.16M | -2.14M | 33.17M | 33.09M | -9.83M |
| Total Operating Expenses | 500.44M | 494.91M | 504.37M | 503.20M | 490.01M |
| Operating Income | 84.70M | 83.76M | 108.78M | 108.53M | 144.52M |
| Income Before Tax | -90.44M | -89.44M | 88.93M | 88.72M | 75.56M |
| Income Tax Expenses | 4.46M | 4.41M | 22.25M | 22.20M | 19.28M |
| Earnings from Continuing Operations | -94.89M | -93.85M | 66.68M | 66.52M | 56.28M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -94.89M | -93.85M | 66.68M | 66.52M | 56.28M |
| EBIT | 84.70M | 83.76M | 108.78M | 108.53M | 144.52M |
| EBITDA | 97.82M | 96.74M | 137.79M | 137.47M | 157.04M |
| EPS Basic | -0.21 | -0.21 | 0.15 | 0.15 | 0.13 |
| Normalized Basic EPS | 0.09 | 0.09 | 0.13 | 0.12 | 0.18 |
| EPS Diluted | -0.21 | -0.21 | 0.15 | 0.15 | 0.13 |
| Normalized Diluted EPS | 0.09 | 0.09 | 0.13 | 0.12 | 0.18 |
| Average Basic Shares Outstanding | 443.90M | 443.90M | 444.10M | 444.10M | 444.10M |
| Average Diluted Shares Outstanding | 443.90M | 443.90M | 444.10M | 444.10M | 444.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.00% | 0.00% | 67.04% | 67.04% | 0.00% |